Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 28, 2015, 91 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $529.45 to $86,394,898.20.

Highlighted Stocks Traded by Insiders:

DexCom (DXCM) - FREE Research Report

Doubleday Richard, who is EVP, Chief Commercial Officer at DexCom, sold 3,258 shares at $70.73 on May 28, 2015. Following this transaction, the EVP, Chief Commercial Officer owned 150,568 shares meaning that the stake was reduced by 2.12% with the 3,258-share transaction.

The shares most recently traded at $71.26, up $0.53, or 0.75% since the insider transaction. Historical insider transactions for DexCom go as follows:

  • 4-Week # shares sold: 27,777
  • 12-Week # shares sold: 51,475
  • 24-Week # shares sold: 67,475

The average volume for DexCom has been 699,200 shares per day over the past 30 days. DexCom has a market cap of $5.7 billion and is part of the health care sector and health services industry. Shares are up 29.46% year-to-date as of the close of trading on Thursday.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. Currently, there are 9 analysts who rate DexCom a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DXCM - FREE

TheStreet Quant Ratings

rates DexCom as a

sell

. Among the areas we feel are negative, one of the most important has been unimpressive growth in net income over time. Get the full

DexCom Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Capitala Finance (CPTA) - FREE Research Report

Arnall Stephen A., who is Chief Financial Officer at Capitala Finance, bought 600 shares at $17.17 on May 28, 2015. Following this transaction, the Chief Financial Officer owned 5,450 shares meaning that the stake was boosted by 12.37% with the 600-share transaction.

The shares most recently traded at $17.42, up $0.25, or 1.44% since the insider transaction. Historical insider transactions for Capitala Finance go as follows:

  • 4-Week # shares bought: 6,185
  • 12-Week # shares bought: 8,685
  • 24-Week # shares bought: 15,785

The average volume for Capitala Finance has been 123,800 shares per day over the past 30 days. Capitala Finance has a market cap of $282.9 million and is part of the financial sector and financial services industry. Shares are down 3.92% year-to-date as of the close of trading on Thursday.

Capitala Finance Corp. is a Business Development Company specializing in investments in traditional mezzanine, senior subordinated and unitranche debt, second-lien loans, equity securities issued by lower and traditional middle-market companies, and small and middle-market companies. The stock currently has a dividend yield of 10.95%. The company has a P/E ratio of 15.3. Currently, there are 9 analysts who rate Capitala Finance a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CPTA - FREE

TheStreet Quant Ratings

rates Capitala Finance as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and notable return on equity. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, weak operating cash flow and a generally disappointing performance in the stock itself. Get the full

Capitala Finance Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TTM Technologies (TTMI) - FREE Research Report

Chung Tai Keung, who is EVP & President, Asia Pacific at TTM Technologies, sold 100,000 shares at $9.74 on May 28, 2015. Following this transaction, the EVP & President, Asia Pacific owned 237,780 shares meaning that the stake was reduced by 29.61% with the 100,000-share transaction.

The shares most recently traded at $9.64, down $0.10, or 1.05% since the insider transaction. Historical insider transactions for TTM Technologies go as follows:

  • 4-Week # shares sold: 23,619
  • 12-Week # shares sold: 23,619
  • 24-Week # shares sold: 101,575

The average volume for TTM Technologies has been 461,000 shares per day over the past 30 days. TTM Technologies has a market cap of $830.9 million and is part of the technology sector and electronics industry. Shares are up 31.08% year-to-date as of the close of trading on Thursday.

TTM Technologies, Inc., together with its subsidiaries, provides various printed circuit board (PCB) products and backplane assemblies worldwide. The company offers high density interconnect, conventional, flexible, and rigid-flex PCBs, as well as backplane assemblies and IC substrates. The company has a P/E ratio of 36.6. Currently, there is 1 analyst who rates TTM Technologies a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TTMI - FREE

TheStreet Quant Ratings

rates TTM Technologies as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income and good cash flow from operations. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. Get the full

TTM Technologies Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.